http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57162704-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3de607e369a55daf2120ea4267a4827
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F8-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F265-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785
filingDate 1981-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1220bf2ed341250d45ff2f507ed569d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51ae3336379a943ebd2ae1ca6266f085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8d237f7f29d8bd526f963829e4de49e
publicationDate 1982-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S57162704-A
titleOfInvention Production of anticoagulant acrylonitrile polymer
abstract PURPOSE: Heparin is made to act on a reaction product between an acrylonitrile polymer, glycidyl acrylate or methacrylate and other vinyl monomers to produce the titled polymer used as a medical macromolecular material with high heparin activity. n CONSTITUTION: (A) Less than 4pts.wt. of acrylonitrile polymer, preferably containing more than 80wt% acrylonitrile and being formed, per 1 pt. of water, (B) 0.0001W0.012pts. of glycidyl acrylate or methacrylate and (C) 0.0005W12pts. of at least one of vinyl monomers other than monomer B are made to react in an aqueous solvent in the presence of a polymerization initiator such as ceric ammonium nitrate (0.01W0.50mmol per 1 liter water) at the freezing point to 60°C in a nitrogen atmosphere. Then, heparin is made to react with the reaction product at room temperature to 90°C. n COPYRIGHT: (C)1982,JPO&Japio
priorityDate 1981-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414862617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453983605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87595
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238

Total number of triples: 32.